Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_assertion type Assertion NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_head.
- NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_provenance.
- NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_assertion evidence source_evidence_literature NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_provenance.
- NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_assertion SIO_000772 21289241 NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_provenance.
- NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_assertion wasDerivedFrom befree-20150227 NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_provenance.
- NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_assertion wasGeneratedBy ECO_0000203 NP675663.RABsTWIEzhB0aRYs3jj2JPw25xwENts_tSxtUCDAMMM94130_provenance.